Krishna Institu.

Which are the latest news on Krishna Institu.?

Why is Krishna Institute of Medical Sciences Ltd falling/rising?

As of 05-Sep, the stock price of Krishna Institute of Medical Sciences Ltd is declining due to a significant drop in net profit and consistent negative results over five quarters, leading to eroded investor confidence. High debt levels and poor financial metrics further contribute to the downward pressure on the stock.

As of 05-Sep, the stock price of Krishna Institute of Medical Sciences Ltd is falling, currently at 764.15, reflecting a change of -3.25 (-0.42%). This decline can be attributed to several factors outlined in the provided data. <BR><BR>Firstly, the company has reported a significant drop in net profit, with a decrease of -31.23%, and has declared negative results for the last five consecutive quarters. This consistent underperformance has likely eroded investor confidence. Additionally, the operating profit has only grown at an annual rate of 4.18% over the past five years, indicating poor long-term growth prospects.<BR><BR>Moreover, the company's financial metrics reveal concerning trends. The operating profit to interest ratio is at its lowest point of 2.68 times, and the return on capital employed (ROCE) has also declined to 8.1, which is below the healthy threshold. The debt-equity ratio is notably high at 1.89 times, suggesting increased financial risk. <BR><BR>While the stock has outperformed the sector by 0.55% today and has high institutional holdings at 49.03%, the overall sentiment is dampened by the company's declining profitability and high valuation metrics. The stock's performance over the past year shows a return of only 3.29%, while profits have fallen by -42.7%, further supporting the notion that the stock is facing downward pressure. <BR><BR>In summary, the combination of poor financial results, high debt levels, and declining profitability are key reasons for the falling stock price of Krishna Institute of Medical Sciences Ltd.

Who are in the management team of Krishna Institu.?

The management team of Krishna Institu includes Bhaskara Rao Bollineni (Chairman & Managing Director), Abhinay Bollineni (Executive Director & CEO), Dandamudi Anitha (Whole-Time Director), and several independent directors, bringing diverse expertise to the company.

The management team of Krishna Institu includes the following individuals:<BR><BR>1. **Bhaskara Rao Bollineni** - Chairman & Managing Director<BR>2. **Abhinay Bollineni** - Executive Director & CEO<BR>3. **Dandamudi Anitha** - Whole-Time Director & Executive Director<BR>4. **Rajeswara Rao Gandu** - Independent Director<BR>5. **Saumen Chakraborty** - Independent Director<BR>6. **Pankaj Vaish** - Independent Director<BR>7. **Ratna Kishore Kaza** - Independent Director<BR>8. **J V Ramudu** - Independent Director<BR>9. **Y Prameela Rani** - Independent Director<BR>10. **Shantanu Rastogi** - Non-Executive Director<BR>11. **Adwik Bollineni** - Additional Director<BR><BR>This diverse team brings a range of expertise and leadership to the company.

What does Krishna Institu. do?

Krishna Institute of Medical Sciences Ltd is a small-cap company in the hospital industry, incorporated in 1973, with recent quarterly net sales of ₹1,180 Cr and a net profit of ₹42 Cr as of June 2026. Key metrics include a P/E ratio of 151.00 and a market cap of ₹31,935 Cr.

Overview:<BR>Krishna Institute of Medical Sciences Ltd operates in the hospital industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was incorporated in 1973 as 'Jagjit Singh and Sons Private Limited'. It changed its name to 'Krishna Institute of Medical Sciences Private Limited' in 2004 and became a public company, adopting the name 'Krishna Institute of Medical Sciences Limited' on January 29, 2004. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 1,180 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 42 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 31,935 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 151.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.85 <BR>Return on Equity: 11.03% <BR>Price to Book: 14.30 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the Krishna Institu.?

Peers of Krishna Institu. include Max Healthcare, Fortis Health, Aster DM Quality, Global Health, Narayana Hrudaya, Dr Agarwal's Health, Rainbow Children's Hospital, Health.Global, and Jupiter Life Line. Krishna Institu. has good management risk and capital structure, with a 1-year return of 4.03%, lower than Aster DM Quality's 25.77% but higher than Max Healthcare's -11.72%.

Peers: The peers of Krishna Institu. are Max Healthcare, Fortis Health., Aster DM Quality, Global Health, Narayana Hrudaya, Dr Agarwal's Hea, Rainbow Child., Health.Global, and Jupiter Life Lin.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Narayana Hrudaya, Global Health, and Jupiter Life Lin, while Good management risk is found at Krishna Institu., Aster DM Quality, Dr Agarwal's Hea, and Rainbow Child. Average management risk is present at Fortis Health. and Health.Global. For Growth, Excellent growth is seen at Max Healthcare and Narayana Hrudaya, while Good growth is noted at Fortis Health., Dr Agarwal's Hea, and Global Health. Below Average growth is reported for Krishna Institu., Aster DM Quality, Rainbow Child., and Jupiter Life Lin. In terms of Capital Structure, Excellent capital structure is found at Max Healthcare and Jupiter Life Lin, while Good capital structure is noted at Krishna Institu., Fortis Health., Narayana Hrudaya, Dr Agarwal's Hea, and Rainbow Child., and Average capital structure is observed at Aster DM Quality and Health.Global.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Aster DM Quality at 25.77%, while the peer with the lowest is Max Healthcare at -11.72%. Krishna Institu.'s 1-year return is 4.03%, which is higher than Max Healthcare but lower than Aster DM Quality. Additionally, the peers with negative six-month returns include Max Healthcare and Fortis Health.

How big is Krishna Institu.?

As of 31st August, Krishna Institute of Medical Sciences Ltd has a market capitalization of 31,935.00 Cr, with recent net sales of 4,212.50 Cr and a net profit of 204.30 Cr over the last four quarters.

As of 31st August, <BR><BR>Market Cap: Krishna Institute of Medical Sciences Ltd has a market capitalization of 31,935.00 Cr, classifying it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 4,212.50 Cr, while the sum of Net Profit for the same period is 204.30 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2026, with Shareholder's Funds amounting to 2,247.40 Cr and Total Assets valued at 7,631.30 Cr.

Should I buy, sell or hold Krishna Institute of Medical Sciences Ltd?

Are Krishna Institute of Medical Sciences Ltd latest results good or bad?

Krishna Institute of Medical Sciences Ltd's latest results show strong revenue growth of 35.33% year-on-year, reaching ₹1,179.50 crores, but net profit fell 47.20% to ₹41.50 crores, raising concerns about profitability and increased debt levels. Overall, while revenue growth is positive, the decline in profit and rising financial risk suggest mixed results.

The latest results for Krishna Institute of Medical Sciences Ltd present a mixed picture. On one hand, the company achieved impressive revenue growth, with net sales increasing by 35.33% year-on-year to ₹1,179.50 crores, marking the highest quarterly revenue in its history. This growth indicates strong demand and operational momentum across its hospital network.<BR><BR>However, the profitability metrics have raised concerns. The net profit for the quarter fell significantly by 47.20% year-on-year to ₹41.50 crores, and the operating margin contracted to 18.94%, down from 22.10% a year earlier. This margin compression is attributed to rising employee costs and increased interest expenses, which surged by 155.83% year-on-year. The company's debt levels have also escalated, leading to a debt-to-equity ratio of 1.89, indicating heightened financial risk.<BR><BR>Overall, while the revenue growth is a positive sign, the sharp decline in profitability and increased debt levels suggest that the results are not entirely favorable. Investors may need to weigh these factors carefully when considering the company's financial health and future prospects.

When is the next results date for Krishna Institute of Medical Sciences Ltd?

The next results date for Krishna Institute of Medical Sciences Ltd is 15 May 2026.

The next results date for Krishna Institute of Medical Sciences Ltd is scheduled for 15 May 2026.

Is Krishna Institu. technically bullish or bearish?

As of December 1, 2025, the trend is mildly bullish due to daily moving averages, but caution is advised as weekly MACD and KST are bearish, despite a bullish weekly RSI and mixed signals from Bollinger Bands.

As of 1 December 2025, the technical trend has changed from sideways to mildly bullish. The current stance is mildly bullish, driven by the daily moving averages indicating bullish momentum. However, the weekly MACD and KST are both mildly bearish, which suggests some caution. The weekly RSI is bullish, supporting the positive outlook, while the Bollinger Bands show a mixed signal with a bullish monthly perspective. Overall, the strength of the bullish sentiment is tempered by the bearish signals in the weekly indicators.

Is Krishna Institu. overvalued or undervalued?

As of November 26, 2025, Krishna Institute is considered very expensive with a PE ratio of 83.68, significantly higher than peers like Apollo Hospitals and Max Healthcare, indicating it is overvalued despite a 14.51% return over the past year compared to the Sensex's 7.01%.

As of 26 November 2025, the valuation grade for Krishna Institute has moved from expensive to very expensive. This indicates that the company is currently overvalued. Key ratios highlight this situation, with a PE ratio of 83.68, an EV to EBITDA of 38.97, and a Price to Book Value of 12.07. <BR><BR>In comparison to peers, Krishna Institute's valuation is notably higher than that of Apollo Hospitals, which has a PE ratio of 63.6 and an EV to EBITDA of 33.45, indicating that Krishna is trading at a significant premium. Additionally, Max Healthcare, another peer, has a PE ratio of 80.02, further emphasizing the elevated valuation of Krishna Institute. While the company has outperformed the Sensex over the past year with a return of 14.51% compared to the Sensex's 7.01%, the current valuation suggests caution for potential investors.

How has been the historical performance of Krishna Institu.?

Krishna Institu has demonstrated consistent growth from March 2020 to March 2025, with net sales increasing from INR 1,122.65 crore to INR 3,035.00 crore, and profit after tax rising from INR 115.07 crore to INR 414.50 crore. The company's total assets and cash flow from operating activities also significantly improved during this period.

Answer:<BR>The historical performance of Krishna Institu shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Krishna Institu's net sales have increased significantly from INR 1,122.65 crore in March 2020 to INR 3,035.00 crore in March 2025, demonstrating a strong upward trend. The total operating income followed a similar pattern, reaching INR 3,035.00 crore in March 2025, up from INR 1,122.65 crore in March 2020. The company's operating profit (PBDIT) also saw substantial growth, rising from INR 251.08 crore in March 2020 to INR 814.60 crore in March 2025. Profit before tax increased from INR 140.53 crore in March 2020 to INR 557.90 crore in March 2025, while profit after tax rose from INR 115.07 crore to INR 414.50 crore in the same period. The company's total assets grew from INR 1,194.47 crore in March 2020 to INR 5,676.10 crore in March 2025, indicating a robust expansion in its asset base. Total liabilities also increased, from INR 1,194.47 crore to INR 5,676.10 crore, reflecting the company's growing financial commitments. Cash flow from operating activities improved from INR 201.00 crore in March 2020 to INR 581.00 crore in March 2025, while net cash inflow turned positive at INR 9.00 crore in March 2025, compared to a net outflow in previous years. Overall, Krishna Institu has shown strong growth in sales, profits, and asset accumulation over the past five years.

Who are the top shareholders of the Krishna Institu.?

The top shareholders of Krishna Institu include promoter Bhaskara Rao Bollineni with 26.27%, mutual funds at 25.35%, foreign institutional investors at 15.45%, and the SBI Small Cap Fund as the largest public shareholder with 6.31%. Individual investors collectively hold 11.24% of the shares.

The top shareholders of Krishna Institu include the promoters, who hold a majority stake in the company. The promoter with the highest holding is Bhaskara Rao Bollineni, with a significant 26.27%. Additionally, mutual funds hold 25.35% of the shares through 24 different schemes, while foreign institutional investors (FIIs) account for 15.45% with 171 FIIs involved. The highest public shareholder is the SBI Small Cap Fund, which holds 6.31%. Individual investors collectively hold 11.24% of the shares.

Has Krishna Institu. declared dividend?

No Dividend History Available